U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180631180631Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.SuspendedNo Results AvailableCardiovascular Disease|Renal Insufficiency, Acute|Cardiopulmonary BypassDrug: N-Acetylcysteine 600mg/tabhttps://ClinicalTrials.gov/show/NCT00190034
180632180632Donepezil Treatment of Psychotic Symptoms in Dementia PatientsNot yet recruitingNo Results AvailableDementia of Alzheimer TypeDrug: donepezilhttps://ClinicalTrials.gov/show/NCT00190021
180633180633Piracetam for Treatment Tardive DyskinesiaCompletedNo Results AvailableTardive DyskinesiaDrug: piracetamhttps://ClinicalTrials.gov/show/NCT00190008
180634180634Clozapine IM and Aggression in Schizophrenic PatientsWithdrawnNo Results AvailableSchizophreniaDrug: clozapine|Drug: haloperidolhttps://ClinicalTrials.gov/show/NCT00189995
180635180635Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101CompletedNo Results AvailableHemophilia ADrug: Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)https://ClinicalTrials.gov/show/NCT00189982
180636180636Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive SubjectsCompletedNo Results AvailableSmallpoxBiological: Elstree-BNhttps://ClinicalTrials.gov/show/NCT00189969
180637180637Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.CompletedNo Results AvailableSmallpoxBiological: IMVAMUNE (MVA-BN)https://ClinicalTrials.gov/show/NCT00189956
180638180638Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy SubjectsCompletedNo Results AvailableSmallpoxBiological: MVA-BNhttps://ClinicalTrials.gov/show/NCT00189943
180639180639An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected PatientsCompletedNo Results AvailableHIV InfectionBiological: MVA-nef|Biological: IMVAMUNEhttps://ClinicalTrials.gov/show/NCT00189930
180640180640Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic DisordersCompletedNo Results AvailableDermatitis, Atopic|Hay FeverBiological: IMVAMUNE (MVA-BN)https://ClinicalTrials.gov/show/NCT00189917
180641180641Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected PatientsCompletedNo Results AvailableHIV InfectionsBiological: IMVAMUNE (MVA-BN)https://ClinicalTrials.gov/show/NCT00189904
180642180642A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic UrticariaWithdrawnNo Results AvailableUrticariaDrug: Methotrexate (drug)|Drug: placebo capsuleshttps://ClinicalTrials.gov/show/NCT00189878
180643180643Supporting Care and Independence at HomeRecruitingNo Results AvailableHeart FailureDevice: Chronic heart failure monitoring system|Device: Lifestyle monitoring systemhttps://ClinicalTrials.gov/show/NCT00189852
180644180644A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney TransplantationCompletedNo Results AvailableKidney TransplantationDrug: tacrolimushttps://ClinicalTrials.gov/show/NCT00189839
180645180645A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.CompletedNo Results AvailableLiver TransplantationDrug: tacrolimushttps://ClinicalTrials.gov/show/NCT00189826
180646180646A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNo Results AvailableIrritable Bowel SyndromeDrug: YM060https://ClinicalTrials.gov/show/NCT00189813
180647180647A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive BladderCompletedNo Results AvailableOveractive BladderDrug: Solifenacin succinatehttps://ClinicalTrials.gov/show/NCT00189800
180648180648Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent AsthmaCompletedNo Results AvailableAsthma, Bronchial|Bronchial AsthmaDrug: tacrolimushttps://ClinicalTrials.gov/show/NCT00189787
180649180649Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic PatientsCompletedNo Results AvailableType 2 Diabetes Mellitus|Diabetes Mellitus, Type IIDrug: nateglinidehttps://ClinicalTrials.gov/show/NCT00189774
180650180650A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT RecipientsCompletedNo Results AvailableBone Marrow Transplantation|Graft Versus Host Disease|Graft-Vs-Host Disease|Graft-Versus-Host DiseaseDrug: Tacrolimushttps://ClinicalTrials.gov/show/NCT00189761
180651180651A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-CompletedNo Results AvailableBone Marrow Transplantation|Graft Versus Host Disease|Graft-Versus-Host Disease|Graft-Vs-Host DiseaseDrug: Tacrolimushttps://ClinicalTrials.gov/show/NCT00189748
180652180652A Study to Evaluate FK778 in Kidney Transplant PatientsCompletedNo Results AvailableKidney Transplantation|Renal Transplantation|Transplantation, Renal|Transplantation, Kidney|Grafting, KidneyDrug: FK778https://ClinicalTrials.gov/show/NCT00189735
180653180653Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent AsthmaCompletedNo Results AvailableAsthma, Bronchial|Bronchial AsthmaDrug: Tacrolimushttps://ClinicalTrials.gov/show/NCT00189722
180654180654Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNo Results AvailableInvasive Candidiasis|CandidemiaDrug: Micafungin|Drug: fluconazolehttps://ClinicalTrials.gov/show/NCT00189709
180655180655Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNo Results AvailableIrritable Bowel SyndromeDrug: YM060https://ClinicalTrials.gov/show/NCT00189696
180656180656Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to ChemotherapyRecruitingNo Results AvailableColorectal CancerProcedure: Monitoring|Procedure: Xelodahttps://ClinicalTrials.gov/show/NCT00189683
180657180657Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast CancerCompletedNo Results AvailableNode Positive Breast CancerProcedure: 6 TEC q 3 weeks|Procedure: 4 EC q 2 weeks followed by 4 TXT q 2 weeks|Procedure: 4 TXT q 2 weeks followed by 4 EC q 2 weekshttps://ClinicalTrials.gov/show/NCT00189670
1806581806585FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal CancerRecruitingNo Results AvailableCancer of the RectumProcedure: 5FU/LV Mayo Clinic or LV5FU2|Procedure: LV5FU2 + irinotecanhttps://ClinicalTrials.gov/show/NCT00189657
1806591806596 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast CancerActive, not recruitingNo Results AvailableBreast CancerProcedure: 6 FEC 100|Procedure: 4 FEC 100 followed by 4 Taxolhttps://ClinicalTrials.gov/show/NCT00189644
180660180660UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to ChemotherapyRecruitingNo Results AvailableBreast CancerProcedure: UFT/LV|Procedure: Observationhttps://ClinicalTrials.gov/show/NCT00189631

* Görseller ve İçerik tekif hakkına sahip olabilir